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Background: Complementary and alternative medicine (CAM), such as acupuncture and herbal medicine, is
popular in many countries. Yet, treatment outcomes of CAM are found to vary significantly between medical trials
in different social environments. This paper addresses how the social organization of medicine affects medical
treatment outcomes. In particular, it examines the extent to which two popular complementary and alternative
medicine (CAM) interventions (acupuncture and herbal medicine) are coordinated with biomedicine and how
coordination characteristics are related to the treatment outcomes of the two CAM interventions.
Methods: This paper conducts an archival analysis of the institutional settings of the CAM interventions in Japan
and the U.S. It also conducts a systematic content analysis of the treatment outcomes in 246 acupuncture reports
and 528 herbal medicine reports that are conducted in Japan or the U.S. and registered in the Cochrane Library’s
Central Register of Controlled Trials (CENTRAL), and 716 acupuncture reports and 3,485 herbal medicine reports that
are from Japan or the U.S. and listed in MEDLINE. It examines the association between the treatment outcomes of
the two interventions and the geographical location of the reports; it also explores how the institutional settings of
the interventions are related to the treatment outcomes.
Results: Japanese herbal medicine is integrated into the national medical system the most and American herbal
medicine the least; American acupuncture and Japanese acupuncture fall in the middle. Treatment outcomes are
the most favorable for Japanese herbal medicine and the least favorable for American herbal medicine. The
outcomes of American acupuncture and Japanese acupuncture fall in the middle.
Conclusions: The co-utilization of CAM with biomedicine can produce difficulties due to tensions between CAM
and biomedicine. These difficulties and subsequent CAM treatment outcomes vary, depending on how CAM is
institutionalized in relation to biomedicine in the national medical system. Coordinated CAM interventions are more
likely to be effective and synergic with biomedicine, when compared to uncoordinated ones.
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Complementary and alternative medicine (CAM), such
as acupuncture and herbal medicine, is popular in many
countries [1-3]. Health care systems have accordingly or-
ganized CAM along with mainstream biomedicine in vari-
ous ways [4-8]. Treatment outcomes of CAM are found
to vary significantly between medical trials in different so-
cial environments [9-11]. However, social scientific inter-
est in the effectiveness and reliability of CAM as a medical
resource [12-16] has paid little attention to an organizational
sociological insight that the social organization of medicine
can affect the outcomes of medical treatments [17,18]. I
draw on this organizational sociological perspective and in-
vestigate how variations in the effectiveness of CAM are re-
lated to differences in the institutionalization of CAM into a
national health care system.
This empirical inquiry is situated at the intersection of
two traditions in medical sociology. One, or the sociology
of medicine, is relatively established in the discipline with
its tenet being the social construction of medicine [19-22].
Its insight is consistent with the observation that CAM
has been constructed and institutionalized differently into
health care systems in the world. The other, or the soci-
ology of the effects of medicine, is relatively nascent in
the literature. Early studies have only demonstrated the
significance of social factors intervening in the outcomes
of biomedicine, by proposing cultural accounts of the
successes or failures of biomedical treatments [23-26],
bio-social models of treatment outcomes [27], and the
society–gene interaction model of genetic causation
[28]. It has yet to be examined how social contextual
influences exist among the puzzlingly varying treat-
ment outcomes of CAM.
At the conjuncture of the two traditions, I hypothesize
that the degree to which CAM is institutionalized within
the mainstream biomedical health care system has conse-
quences for the effects of CAM. This hypothesis is based
on existing ethnographic observations that the institu-
tional settings of CAM affect how users perceive and
what they expect from CAM treatments [29] and that
negative social labeling of illnesses and unconventional
medicines may lead to secretive and uninformed uses of
informal medical resources ([30]: 1814). Most import-
antly, this hypothesis pays heed to the theoretical and
political tensions and conflicts between CAM and bio-
medicine in addressing illnesses [20,31-33]. In addition,
the tensions and conflicts can vary, depending on the ex-
tent to which CAM is institutionalized within the domin-
ant biomedical system. When institutionalized, CAM is
likely to have less tensions and conflicts with biomedicine.
Varying tensions and conflicts can subsequently shape
how CAM is practiced alongside biomedicine in specific
treatment contexts, which has in turn consequences for
the treatment outcomes of CAM.The purpose of this paper, therefore, is twofold. First, I
investigate quantitatively whether there is a discernible
correspondence between CAM institutionalization and
CAM treatment outcomes. Second, I provide a sociological
explanation of the correspondence by qualitatively revealing
specific treatment episodes from reports in medical journal
databases.
I take a methodological cue from the medical science
community (i.e. the meta-analytic approach based on a
systematic content analysis) and adapt it into a socio-
logically informed meta-analysis. The medical science
community has responded to the inconsistent outcomes
of medical interventions with meta-analyses of research
findings [34-36]. Meta-analyses are expected to produce
generalizable evidence by adjusting inconsistent outcomes
to differences in trial design (e.g. the size of trial subjects),
outcome measures, or the statistical models used. Indeed,
some early agreements have ensued with regard to the ef-
ficacy and safety of CAM interventions [37-39].
Medical meta-analyses, however, have two significant
limitations compared to medical sociological interests.
First, they neglect the treatment outcomes reported by
users and practitioners in real-world medical practices
outside “scientific” clinical trials. Aiming to re-calibrate
the effects of only technological interventions arguably in-
dependent of social circumstances, medical meta-analyses
focus on clinical trials (e.g. randomized controlled trials
[RCTs]) where the impacts of the social environment are
designed to be non-existent. Thus, they have excluded
treatment outcomes that are reflected in patient case re-
ports and practitioner commentaries in medical journals.
Treatment outcomes in real-world treatment settings out-
side clinical trials and those from practical medicine in
clinics rather than theoretical science in laboratories have
been obscured.
Second, the variations in treatment outcomes across
doctors’ offices and hospitals have also been obscured.
Medical meta-analyses aim at generating consensus rather
than identifying disagreements. The limitation of this
approach to re-calibrating the universal – rather than
differential – effects of medical interventions is evident,
when acupuncture and herbal medicine of an identical
quality and of an identical trial design (a randomized
controlled trial [RCT]) are intriguingly found to pro-
duce varying and even conflicting treatment outcomes
at different trial sites [10,11].
Through a sociological meta-analysis, I purport to sys-
tematically document the varying outcomes of CAM in
two different social contexts. My analysis aims not to
bracket these variations out of consideration, as medical
meta-analyses have done in search of the universal ef-
fects of CAM interventions. Instead, I examine two
popular CAM treatments, acupuncture and herbal medi-
cine, to show how divergent their treatment outcomes
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these treatment outcomes are related to the institutional
environment of the interventions in the two countries. I
stress the significance of coordinating acupuncture and
herbal medicine treatments with mainstream biomedi-
cine in order for the CAM interventions to produce tan-
gible health care benefits. I also argue for the relevance
of a sociological meta-analysis to identify and explain
the differential outcomes of medicine.Data and methods
Case selection: acupuncture and herbal medicine in Japan
and the U.S.
I examine the treatment outcomes of acupuncture and
herbal medicine in Japan and the U.S. for two reasons.
First, acupuncture and herbal medicine are institutional-
ized differently in the two countries. Theoretically, acu-
puncture and herbal medicine together form the whole
system of “oriental medicine” or “traditional Chinese
medicine”. Japan and the U.S. have, however, institutional-
ized acupuncture and herbal medicine being disconnected
from each other. Furthermore, the two countries show re-
versed institutional prominence between acupuncture and
herbal medicine. Acupuncture has been incorporated into
the American medical system as one of the legitimate
medical practices, whereas herbal medicine still remains
illegitimate. In Japan, to the contrary, both have been in-
stitutionalized into the national medical system, where
herbal medicine has gained the status of a legitimate
medicine as kampo whereas acupuncture has been insti-
tutionalized as a second-class pseudo-medicine.
Second, studies suggest cross-national differences be-
tween East-Asian countries and Euro-American countries
in the degree to which acupuncture and herbal medicine
are found to be effective [9,40,41]. Among these countries,
Japan and the U.S. are two of the countries that conduct
most medical research in the world [42]. Thus, they do
not only provide the richest empirical reports about the
treatment experiences of acupuncture and herbal medi-
cine but also constitute an interesting pair that invites a
sociological investigation of how different institutional set-
tings are related to treatment outcomes.Meta-analysis
To specify the treatment outcomes of acupuncture and
herbal medicine in the two countries, I have used med-
ical journal papers as the unit of analysis. Medical jour-
nal papers are from two prominent medical databases:
the Cochrane Library’s Central Register of Controlled
Trials (CENTRAL) (http://www.thecochranelibrary.com/)
and the U.S. National Library of Medicine’s MEDLINE
(http://www.nlm.nih.gov/bsd/pmresources.html) both of
which hold medical reports from across the world.As of May 2012, there are 673,964 controlled clinical
trials registered in CENTRAL. I have retrieved 5,243 trials
of acupuncture, which refer to “acupuncture” in the title,
abstract, or keywords. Of the total acupuncture trials, 108
and 138 trials have been conducted by researchers based
in Japan and the U.S., respectively. I have retrieved a total
of 5,812 trials on herbal medicine, which refer to “herbal
medicine”, “herbal therapy”, “herbal supplement”, “herbal
preparation”, “herbal remedy”, “kampo”, “kanpo”, “me-
dicinal plant”, or “plant extract” in the title, abstract, or
keywords. Of these trials, 228 have been conducted by
researchers in Japan and 300 in the U.S. I analyze the
content of all 246 acupuncture trials and 528 herbal
medicine trials. I focus on four measures: treatment effect-
iveness, biomedicine–CAM synergy, adverse treatment
outcomes, and negative biomedicine–CAM interactions.
As of 2012, the second database, MEDLINE, includes
over 700,000 records in the subset of CAM (“Complemen-
tary Medicine”) that is developed by the U.S. National
Center for Complementary and Alternative Medicine
(NCCAM) (for the detailed strategies used for the subset,
see http://www.nlm.nih.gov/bsd/pubmed_subsets/comp_
med_strategy.html). Unlike CENTRAL which lists only
controlled clinical trials, MEDLINE covers various reports,
such as patient case reports, practitioner opinions and
comments, news reports, policy analyses, and historical
reviews (see Table 1 for details). Thus, MEDLINE uniquely
incorporates reports from users and practitioners in real-
world medical practices outside of controlled laboratorial
trials. Based on Boolean search queries where I utilize the
MeSH (Medical Subject Headings) terms for CAM modal-
ity and geographical location (see Appendix for each
query in detail), I have retrieved 115 reports of acupunc-
ture practiced in Japan and 601 reports in the U.S. as of
May, 2012; there are 1,071 reports of herbal medicine
from Japan and 2,414 reports from the U.S. Table 1 pre-
sents how these reports are distributed across different
report types.
I analyze the content of all 716 acupuncture reports
and 3,485 herbal medicine reports in the same four mea-
sures. The four measures have been operationalized in
the following. I apply the method of “closed coding” [43]
in which I code each report 1 or 0 for each of the four
measures, depending on whether the report provides a
positive or a negative answer to a pre-determined ques-
tion for the measure.
First, treatment effectiveness measures whether acu-
puncture or herbal medicine intervention was found to
be effective in treating or preventing medical condi-
tions, compared to the outcomes in pre-treatment or
control groups. When a paper found the intervention
effective, the paper is coded 1 (0 otherwise).
Second, biomedicine–CAM synergy refers to the pres-
ence of positive outcomes from the concurrent use of
Table 1 Types of the MEDLINE Reports Included in the Analysis
Report Type Reports about Acupuncture Reports about Herbal Medicine
from Japan from the U.S. from Japan from the U.S.
Clinical Trials 10 (8.3%) 27 (4.4%) 42 (3.9%) 48 (2.0%)
Case Reports 5 (4.2%) 13 (2.1%) 12 (1.1%) 54 (2.2%)
Professional Opinions 3 (2.5%) 45 (7.3%) 31 (2.9%) 176 (7.2%)
Reviews 13 (10.8%) 110 (17.8%) 58 (5.4%) 331 (13.5%)
Historical Articles 33 (27.5%) 39 (6.3%) 97 (8.9%) 178 (7.2%)
News Articles 0 (0.0%) 24 (3.9%) 6 (0.6%) 194 (7.9%)
Unclassified 51 (42.5%) 343 (57.1%) 825 (77.0%) 1433 (59.4%)
Total 115 (100.0%) 601 (100.0%) 1071 (100.0%) 2414 (100.0%)
Note: Report types are based on the categories in the “Article Type” filter in MEDLINE (accessible online at PubMed). The MEDLINE classification system has
dozens of categories that are not unidimensional or mutually exclusive. Some of them are relevant to considering the medical scientific quality of the reports
(e.g. report types included in this table), while others are not (e.g. funding sources of the reports). I include controlled clinical trials, randomized controlled trials,
and clinical trials under the type of “clinical trials;” “case reports,” historical articles,” and “news articles” are distinct categories of themselves as classified in the
system; “professional opinions” include comments, letters, editorials, interviews, and addresses.” “Reviews” include unsystematic reviews, systematic reviews, and
meta-analyses. When a report is not indexed with any of these categories, it is grouped into “unclassified.”
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From the data, two types of synergy have emerged. First,
the combined treatments of biomedicine and CAM were
often found to be effective when the lone treatment of ei-
ther biomedicine or CAM was not. In other cases, the ef-
fectiveness of combined treatments was found greater
than that of either lone treatment. Second, synergy was
shown in cases where CAM was used to relieve the side
effects of biomedical treatments and to help patients to
continue their biomedical treatments. Without CAM and
its synergic effects, it would have been difficult to continue
the biomedical treatments.
Third, adverse treatment outcomes refer to the pres-
ence of unforeseen adverse medical events from CAM
(coded 1; 0 otherwise). I code adverse events as were re-
ported in clinical trials in CENTRAL; for reports from
MEDLINE, I use the MeSH term “adverse effects” to
code the presence.
Fourth, negative biomedicine–CAM interactions meas-
ure the presence of adverse treatment interactions be-
tween biomedicine and CAM (coded 1; 0 otherwise).
Whereas adverse treatment outcomes refer to adverse
events from CAM only, this measure reflects adverse
events that occur through the interactions between bio-
medicine and CAM. I code the interactions as reported
in CENTRAL trials; I use the MeSH term “herb–drug
interactions” for MEDLINE reports. Negative herb–drug
interactions are defined as adverse outcomes that are
not expected of separate applications of each of the con-
currently used drug and herbal medicine ([44]: 631).
Through this coding process, each report is given a
value of 1 or 0 for each of the four measures of treatment
outcomes. In addition, each report is coded whether it is
about acupuncture or herbal medicine (modality); whether
it is from Japan or the U.S. (geographical location). Then, I
use Pearson’s χ2 test of independence for the relationshipbetween the geographical location (Japan vs. the U.S.) and
each of the four measures of treatment outcomes and that
between modality (acupuncture vs. herbal medicine) and
each of the four measures. This test gives quantitative an-
swers to whether there are cross-national differences in
CAM treatment outcomes between Japan and the U.S. and
how they correspond to differences in the institutional set-
tings of acupuncture and herbal medicine. This quantitative
test of independence between the institutional settings of
CAM treatments in different countries on the one hand
and the treatment outcomes on the other constitutes the
first unique feature of the sociologically informed meta-
analysis that this paper performs.
In addition, I complement this quantitative analysis
with a qualitative analysis, by extracting the details of in-
stitutional settings from the reports. I apply the method of
“open coding” [43] to discover themes related to the treat-
ment contexts in which acupuncture or herbal medicine is
practiced. For each report, therefore, these contexts are
coded descriptively in text. Several themes have emerged
from this open coding process that explain the results
from the quantitative analysis, such as practitioner skills,
the holistic practices of CAM, the organizational coordin-
ation of CAM with biomedicine, patient–physician com-
munication of CAM use, and cross-cultural utilization of
healthcare services. This open coding process, which
focuses on the treatment contexts and subsequently ex-
tracts these themes emerging from the contexts, is the
second unique feature of the sociologically informed
meta-analysis.
The emergent themes from the open coding process
are all grounded in the reports that I refer to with unique
document identifiers: CENTRAL-generated CNIDs (i.e. 8-
digit numbers led by “CN–”) and MEDLINE-generated
PMIDs (i.e. 8-digit numbers led by “PMID”). With these
unique identifiers, one can easily access the full reports in
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at http://www.thecochranelibrary.com/view/0/index.html;
use PMIDs in the search box at http://www.ncbi.nlm.nih.
gov/pubmed).
Results from the comparison of the institutional settings
in Japan and the U.S.
Japan: acupuncture and herbal medicine integrated into
the medical system
Japanese herbal medicine kampo literally means “Chinese
or Oriental (kam) theory or therapeutics (po)” that does
not only include herbal medicine but also acupuncture,
cupping, and moxibustion. Since the 1970s, however,
kampo refers in practice to herbal medicine only. Herbal
medicine has since managed to remain at the center of
traditional oriental medicine whereas other elements, such
as acupuncture and moxibustion, have been marginalized.
From a historical perspective, however, it was herbal
medicine, rather than acupuncture, that was first mar-
ginalized. First established as traditional medical prac-
tices in the 6th century [45], acupuncture and herbal
medicine underwent major tumults during the Meiji
government-driven medical modernization (1868–1912).
Meiji legalized only medical practices that were adopted
from the Netherlands and Germany. Both acupuncture
and herbal medicine were denied legal recognition.
Around 1885, however, acupuncture gained official recog-
nition from prefecture governments as a vocational course
for the blind and not as a legitimate medical tradition. The
reinstatement of acupuncture in the vocational context cul-
minated in the 1911 legislation that permitted the practices
of acupuncture and moxibustion as business entities and not
as medical practices. It was under the post-World War II
American rule that acupuncture and moxibustion were rec-
ognized as medical practices that required formal education
and licensure ([46]: 8–9).
Acupuncture education was further formalized, as it ex-
panded into universities like Meiji Shinkyu Daigaku estab-
lished in 1983. Subsequently, the Japanese government
initiated a nation-wide standardized licensure in 1993, re-
placing the fragmented systems overseen by local govern-
ments. Acupuncture has since maintained the institutional
recognition. Currently, there are 80 three-year vocational
schools, 6 four-year colleges occasionally with post-graduate
programs, and medical schools all teaching acupuncture as
a required or elective course [47-49]. It is estimated that
there are about 130,000 licensed and 80,000 practicing acu-
puncturists in about 50,000 clinics throughout Japan [50].
National surveys estimate that 6–7% of Japanese adults visit
acupuncture clinics [51,50].
To the contrary, herbal medicine remained outlawed
for a century from 1868 to 1967. Then, four traditional
herbal medicine (kampo) formulae in 1967 and 43 for-
mulae in 1976 were suddenly recognized by the nationalgovernment and sanctioned in the national insurance
system, comparable to pharmaceutical drugs [52,53]. Sev-
eral accounts exist for this sudden institutional acceptance
of kampo after a century of long neglect, some of which
stresses the strong lobbying of the Japanese Medical Associ-
ation [54], the needs of patient groups, or the business in-
terests of kampo manufacturers [53]. Kampo has since been
prescribed only by medical doctors like biomedical drugs.
This reinstatement of herbal medicine into the center
of medicine has in fact been accompanied by several de-
liberate – although hidden – efforts. First, doctors at
Meiji-era medical schools kept studying kampo and con-
ducting research with students, even though they could
not teach it officially ([55]: 7). The successful pharmaco-
logic isolation of alkaloid ephedrine from the kampo herb
mao (Ephedra sinica) in 1887 was another achievement
([56]: 52). Facing denial from the Meiji government,
kampo researchers appropriated government-espoused
pharmaceutical models for underground research into
kampo and produced the achievement. Second, unofficial
kampo research by three distinct groups of medical doc-
tors brought about a historic event in kampo, or the publi-
cation of The Practice of Clinical Kampo Medicine in 1941
([55]: 7–8). The publication provided a list of formulated
kampo prescriptions that are matched to patient symptoms.
Thus, physicians without theoretical knowledge of kampo
were able to practice it with a ready-made set of symptom-
specific formulae. This publication was followed by the
Japanese Medical Association’s endorsement of kampo for
its acceptance into the national insurance system.
Several regulatory measures, comparable to those of bio-
medical drugs, further promoted the full institutionalization
of herbal medicine, such as the introduction of toxicity tests,
three-phased clinical trials, and efficacy evaluations [53,57].
Currently, 148 formulae and over 200 herbs are being sup-
ported by the national health insurance system [52]. Herbal
remedies can be purchased from pharmacies with the sup-
port of national insurance when they are prescribed by a
physician or without the insurance support when there is no
physician prescription. About 70% of physicians reportedly
prescribe kampo (Nikkei Medical October 2003: 33–39).
The total annual expenditure for kampo is estimated to
be more than one billion dollars [56]. Following a gov-
ernment mandate, 79 out of the 80 Japanese medical
schools teach kampo courses. There are 2,420 kampoi
(or, board-certified physicians for kampo practices) and
about 6,000 non-certified kampo-practicing physicians
among the total number of 280,000 physicians (http://
www.jsom.or.jp/).
The U.S.: acupuncture integrated in the system while herbal
medicine being an outcast
Not until the 1970s did acupuncture and Oriental medi-
cine (AOM) begin to be officially recognized by state
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underground medical practices known only to Asian
immigrant communities [58]. From the 1970s, acu-
puncture was readily decoupled from the whole system
of Oriental medicine and achieved early acceptance in
the American medical system. Herbal medicine, on the
contrary, is still left outside of the established medical
field.
The relatively advanced institutionalization of acupunc-
ture began with practitioner associations organized in the
1970s. Along the way, acupuncture schools were formed,
resulting in 13 acupuncture and oriental medicine schools
by 1981 [59]. State-level developments soon led to the
birth of national organizations and orchestrated examin-
ing bodies [60,61]. By 1982, a decade after the initial
organizing efforts, acupuncture established itself as a self-
sufficient medical profession with its own education, certi-
fication, and practitioner associations at the national level.
Most state governments subsequently began legalizing the
practice of acupuncture.
American acupuncture has also been established in
other institutional measures. In 1996, the Food and Drug
Agency (FDA) reclassified acupuncture needles as “safe
and effective medical devices”, replacing the 1973 classifi-
cation as experimental “investigational devices” [61]. The
National Institute of Health (NIH) produced a consensus
report in 1997 supporting the potential efficacy of acu-
puncture [39]. Over 65 schools and colleges confer either
a 3-year Master of Acupuncture degree, a 4-year Master
of Acupuncture and Oriental Medicine degree, or a Doc-
tor of Acupuncture and Oriental Medicine [62]. There are
over 27,000 licensed acupuncturists in 45 states, five of
which even allow acupuncturists to hold the title of pri-
mary care practitioner (PCP) who can perform biomedical
test requests and patient referrals to other specialists. In-
surance coverage is relatively limited yet. Federal health-
care schemes do not cover acupuncture and less than a
quarter of state Medicaid programs cover acupuncture
[63]. Eleven states have private insurance mandates [64].
About 47% of private policies cover acupuncture and they
limit reimbursement to visits only to physician acupunc-
turists or pre-designated acupuncturists [65].
The current institutional status of herbal medicine is
much less prominent than acupuncture. There is no sole
medical degree of herbal medicine or certification of
herbalists. Instead, acupuncture schools have gradually
promoted herbal medicine by expanding the scope of
practice by acupuncturists. It is, however, still illegal for
acupuncturists to practice herbal medicine in half of the
states [62]. Chiropractors, naturopaths, and midwives
may only occasionally practice herbal medicine [64]. A
majority of herbalists are food and nutrition specialists
and not medical practitioners. This institutional under-
development is surprising, considering herbal medicine’scentral position within Oriental medicine and its long
tradition in Native American medicine ([66]: 190, [67]).
The current status of herbal medicine practiced mostly
in food stores and not by medical professionals is related to
the American history of food and drug regulation. Manu-
facturers of herbal medicine have managed to define herbal
medicine as “dietary supplements”, a regulatory category
for a subgroup of food under the 1994 Dietary Supplement
Health and Education Act (DSHEA). Accordingly, herbal
medicine is not required to be registered and approved by
the FDA for safety or efficacy. Manufacturers are required
only to report its post-marketing adverse side effects while
herbs cannot be marketed to have any medical effects [68].
Competing efforts still exist to place herbal medicine
under the category of legitimate medicine rather than
dietary supplements. On one hand, medical doctors have
requested to officially recognize the high physiological
potency of herbal medicine and bring it under strict
FDA regulations equivalent to drugs [69,70]. On the
other, acupuncturists have tried to enlist herbal medicine
under the scope of practice by acupuncturists. Mean-
while, manufacturers can supply herbal medicine directly
to users without any mediation from physicians, nurses,
acupuncturists, or herbalists.
Results from the meta-analysis of treatment outcomes
Treatment effectiveness
I found a cross-national difference in the treatment ef-
fectiveness of acupuncture and herbal medicine in both
CENTRAL and MEDLINE. Acupuncture was found to
be more effective in Japan than in the U.S. Eighty four
out of 108 Japanese trials and 87 out of 138 American
trials in CENTRAL found it effective (78% vs. 63%;
p-value for Pearson’s χ2 test of independence = 0.013).
Eleven out of 115 Japanese reports and 40 out of 601
American reports in MEDLINE found it effective (10%
vs. 7%; p-value = 0.266).
Correspondingly, acupuncture and herbal medicine
were practiced differently in Japan and the U.S. First,
acupuncturists had different skill levels. Experienced
acupuncturists applied acupuncture needles in the fol-
lowing first trial, whereas, in the second trial, staff
nurses and research assistants practiced acupuncture
with minimal training.
“[State-licensed] senior acupuncturists (5 + years in
practice) decided where to needle and junior
acupuncturists (2 - years in practice) practiced the
interventions”. (CN-00735199)“Dr. Ji-Sheng Han … provided an in-depth training to
Dr. Meade and Ms. Eldridge. They, in turn, trained
study staff (research assistants and nurses)… This staff
was certified to administer treatments”. (CN-00728884)
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that a Japanese kampo formula (i.e. keishibukuryogan),
which had been found efficacious for menopausal symp-
toms in Japan, produced unexpected adverse effects (i.e.
diarrhea) in 20% of the trial subjects in the U.S. and only
marginal treatment effects, a report pointed out the defi-
cient knowledge about the proper dosage of kampo for
American women (CN-00810843). The American trial
had simply followed the dosage instruction made in the
Japanese context. Two more studies evidenced that
cross-national outcome differences were related to more
or less informed ways of practicing herbal medicine
(CN-00482723; CN-00750876).
Second, American trials applied acupuncture in a frag-
mented and less effective way, compared to the holistic
Japanese practices. For example,
“Acupuncture treatments were performed at the
Harvard-Thorndike General Clinical Research Center
at Beth Israel Deaconess Medical Center. … However,
massage, herbal prescriptions (or any other medical
prescription), moxa, cupping, and lifestyle modifying
therapies were not allowed”. (CN-00610755)“Limitation: A prescription of acupuncture at fixed
points may differ from acupuncture administered in
clinical settings, in which therapy is individualized
and often combined with herbal supplementation and
other adjunctive measures”. (CN-00511534)
Better outcomes were indeed found in a “whole sys-
tem clinical trial” that adhered to the holistic prac-
tices (CN-00640342). A growing emphasis is placed on
“pragmatic” trials designed to capture the overall impact
of acupuncture as a whole system vis-à-vis the fragmented
“drug model” of trials [71].
Third, treatment effectiveness was dependent upon
whether acupuncture was coordinated with other con-
ventional treatments. For example, two clinical trials
conducted on the same site, on the same subjects (i.e.
cocaine-dependent patients at the Yale School of Medicine),
and with the same acupuncture treatment, produced
different treatment results (CN-00403270). Acupunc-
ture was ineffective in treating cocaine addiction in one
trial; it was effective in the other. In the effective trial,
subjects were additionally provided with a manual-based
conventional psychological therapy called “coping skill
therapy (CST)” which was absent in the ineffective trial.
So, the study concluded that:
“acupuncture, a nonverbal treatment that does not in
and of itself teach skills requisite for abstinence, may
need to be embedded within an appropriate
psychological framework in order to be effectivelyutilized. … The absence of the CST may have
constituted a significant omission”. (CN-00403270)
Biomedicine–CAM synergy
In the Pearson χ2 test of independence among the
CENTRAL trials, herbal medicine was found to produce
synergy with biomedicine more often in Japan than in
the U.S. (13% vs. 3%; p-value < 0.001). The cross-
national difference was less obvious in acupuncture (22%
vs. 11%; p-value = 0.028). In Japan, herbal medicine was
found to be as synergic with biomedicine as acupuncture
was (13% vs. 11%; p-value = 0.674). In the U.S., to the
contrary, herbal medicine was significantly less synergic
than acupuncture (9% vs. 30%; p-value < 0.001).
The details of biomedicine–CAM synergy were identi-
fiable in two categories. First, synergy was represented in
an additive manner. For many medical conditions, the
addition of acupuncture or herbal medicine to biomed-
ical treatments often produced effective treatment re-
sults, compared to the ineffective lone treatment of
either biomedicine or CAM. The addition sometimes
produced greater effects, compared to the effects of ei-
ther lone treatment.
For example, acupuncture produced additive effects on
infertile women under in-vitro fertilization treatments
(CN-00730574; CN-00768745; CN-00700432), opioid
drug addicts on medications (CN-00728884), cancer
survivors under biomedical treatments for neck pain
(CN-00761076), people on medications for chronic
musculoskeletal pains (CN-00720285; CN-00457236),
and people on medications for irritable bowel syndrome
(CN-00698848). Acupuncture also produced analgesic or
anesthetic benefits to pediatric surgery (CN-00734541),
cardiac surgeries (CN-00720700), oncological surgeries
(CN-00579120; CN-00664750), and dental surgeries
(CN-00330168).
Herbal medicine produced additive synergy among
people with rheumatoid arthritis on a conventional
medication (CN-00729697), surgical patients under a
variety of post-operative cares for surgery-induced in-
testinal bowel syndrome, inflammation, liver dysfunction,
and pains (CN-00668598; CN-00686725; CN-00410068;
CN-00556925; CN-00347524; CN-00434525; CN-00609214;
CN-00512697; CN-00373691; CN-00793124; CN-00790633;
CN-00793458), and cancer patients under radiation ther-
apy (CN-00132749; CN-00347726; CN-00330625).
Second, biomedicine–CAM synergy was revealed in an
interactive and corrective way, as well. In this case,
CAM was used to relieve the adverse side effects of bio-
medical treatments and help patients to continue bio-
medical treatment until they got desirable treatment
outcomes from biomedicine.
For example, acupuncture helped HIV patients to con-
tinue HAART (Highly Active Anti-Retroviral Therapy)
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on HAART, such as diarrhea, nausea, and vomiting
(CN-00558827; PMID 21705396). It also reduced vaso-
motor symptoms, such as hot flashes and night sweats,
developing from anti-estrogen hormone therapy on
breast cancer patients and, thus, helped the patients to
continue biomedical cancer treatments (CN-00700744;
CN-00733070). At the same time, acupuncture pro-
duced fewer adverse effects than venlafaxine (a conven-
tional antidepressant for cancer patients on anti-estrogen
treatment) and more positive outcomes, such as energy
and sex drive (CN-00733070). In addition, acupuncture
was found effective for managing a common side effect
(joint pains) of the AI hormone therapy for early breast
cancer patients who often discontinued the hormone
therapy due to the side effect (CN-00649930; CN-
00729624). Acupuncture also slowed the decrease in
the ability of bone marrow to produce blood cells, a
side effect of chemotherapy for gynecologic cancers
(CN-00722277).
In herbal medicine, the kampo remedies maoto and
shosaikoto were found effective in reducing discomfort,
general malaise, and arthralgia induced by the estab-
lished interferon treatment for patients with chronic
hepatitis C, while not reducing the interferon’s antiviral
effects and sometimes improving its effects (CN-00794206;
CN-00793700; CN-00472711). Another group of herbal
remedies helped cancer patients to continue biomedical
treatments, by relieving the side effects of cancer treat-
ments, such as neurotoxicity, diarrhea, and insomnia
(CN-00728144; CN-00437238; CN-00779065). Exam-
ples in other contexts were juzentaihoto for addressing
anemia in patients on hemodialysis (CN-00667345),
rikkunshi-to for adverse gastrointestinal symptoms
among people on anti-depressant fluvoxamine (CN-
00795653), and maca root for anti-depressant SSRI-
induced sexual dysfunction (CN-00665598).Adverse treatment outcomes of CAM
Among the CENTRAL trials, I found no reports of
adverse treatment outcomes from acupuncture in
Japan or the U.S., whereas there were several trials of
herbal medicine in the U.S. where unforeseen difficul-
ties developed. Reported events were diarrhea caused
by a Japanese kampo formula keishibukuryogan used
for menopausal symptoms (CN-00810843), high blood
pressure among users of athletic performance-enhancing
dietary supplements (CN-00647862), increased blood
pressure and heart rates among people who took bitter
orange for controlling obesity (CN-00553213), and the
damaging effects on male reproductive cells from St.
John’s wort, ginkgo, and echinacea in high concentra-
tions (PMID 10065791).In the MEDLINE reports as well, herbal medicine was
found to produce adverse outcomes more often than
acupuncture. Adverse treatment outcomes were men-
tioned in 23% of the 3,485 herbal medicine reports vs.
5% of the 716 acupuncture reports (p-value < 0.001). In
the U.S., this contrast between herbal medicine and acu-
puncture was greater (25% vs. 4%; p-value < 0.001),
whereas the contrast was significantly weaker in Japan
(16% vs. 10%; p-value = 0.078). Put in a cross-national
perspective, herbal medicine produced more adverse
outcomes in the U.S. than in Japan (25% vs. 17%; p-value <
0.001); acupuncture produced adverse outcomes less often
in the U.S. than in Japan (4% vs. 10%; p-value = 0.010).
Content analysis revealed some of the specific occasions
that contributed to producing these adverse events. Out of
the 12 Japanese reports of adverse effects from acupunc-
ture, a majority reported minor injuries, such as localized
argyria and minor hemorrhages, caused by acupuncture
needles left in the body (PMID 1464937; PMID 11444889;
PMID 12459543; PMID 20934166). In most cases, tiny
acupuncture needles were intentionally and permanently
embedded in patient bodies for therapeutic purposes ac-
cording to Japanese acupuncture theory. On the other
hand, major injuries were often caused by accidentally
broken needles during laypeople’s self-treatments.
Another common category of the adverse effects
was virus infection through improperly sterilized acu-
puncture needles, such as hepatitis C virus infections
(PMID 9816817; PMID 8194707; PMID 7689501; PMID
1908912) and other infections (PMID 1488961). Un-
like the reports of minor injuries, these infection re-
ports originated in earlier years. According to more
recent reports, the association between acupuncture
and infection was found to be weak in hepatitis C
virus (PMID 7681088; PMID 8329759; PMID 9033214;
PMID 9094854; PMID 10756668) and HIV (PMID
8329759; PMID 9094854).
Reports of needle-induced infections existed in the
U.S. as well, such as the contraction of hepatitis C
(PMID 22239506; PMID 16379222; PMID 10235216)
and hepatitis B (PMID 3341362; PMID 3944549; PMID
3417241). Some other U.S. reports were about sub-
arachnoid hemorrhages and spinal injuries in a Latino
immigrant who visited an unproven thoracic acupunc-
turist in California (PMID 1464937), forgotten needles
and minor hemorrhages from poorly-trained practi-
tioners (PMID 11829162; PMID 11874310), minor skin
problems from moxibustion (PMID 3965232), contact
dermatitis from needles, and unspecific general worries
about acupuncture (PMID 1137233; PMID 4406704;
PMID 4408150; PMID 4607022; PMID 4590887). Across
these reports, the lack of practitioner skills or institutional
regulations on practitioner education was found to be a
cause of the adverse events.
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Out of the 3,485 MEDLINE reports on herbal medicine,
only a small fraction (39 reports; 1.1%) reported negative
interactions with biomedical drugs. While reports of
negative interactions were rare in general, I found a sig-
nificant cross-national difference in the proportion of
these reports among all the reports on herbal medicine
(0.1% in Japan vs. 1.6% in the U.S.; p-value < 0.001).
Thirty eight out of the total 39 reports of negative interac-
tions were from the U.S., except for one Japanese report
about a 48 year old woman who developed extensive red
round rashes over her legs hours after she took kakkoto
for general fatigue. This woman was already taking several
medications for atypical psychosis when she took kakkoto.
These drugs in combination with the herbal medicine
kakkoto reportedly developed the adverse interactions
(PMID 14674921).
A majority of U.S. reports (24 out of 38) were about
popular herbal supplements, such as garlic, ginkgo, echin-
acea, ginseng, St John’s wort, and kava, and their potential
interactions with drugs among the general population as
well as among patients with cancers, cardiovascular
conditions, or endocrine disorders. These reports stressed
mostly that adverse interactions could be prevented by
doctors and nurses who elicit the history of patients’
herbal medicine use (PMID 10737289; PMID 19390395)
and prescribe herbal supplements appropriately based on
this history (PMID 15581442). The following is an exem-
plar quote about how drug–herb interactions could com-
plicate biomedical treatments.
“CAM and antiretroviral therapies [for HIV patients]
can produce side effects, such as weight loss.
Additional drug interactions with nutritional
supplements can increase health complications. …
Providers may attribute these adverse effects to the
antiretroviral drug, prompting them to incorrectly
switch [antiretroviral] medications. This can be
expensive and may lead to increased antiretroviral
resistance. These and similar situations can be
avoided by creating and maintaining an open dialogue
about CAM use”. (PMID 19181175)
Among the CENTRAL trials, there was no report of
acupuncture producing adverse treatment interactions
with biomedicine. On the other hand, among trials of
herbal medicine, I found three types of adverse treatment
interactions between herbal medicine and biomedicine.
First, herbal medicine interfered with biomedical treat-
ments as follows: St. John’s wort’s interference with
contraceptives (CN-00528293), oncological drugs (CN-
00491970), and intestinal P-glycoprotein (CN-00470658);
American ginseng’s interference with Warfarin’s anti-
coagulant mechanism in postoperative care (CN-00467683).Second, herbal medicine inadvertently concentrated the
effects of biomedical drugs. For example, ephedrine’s
co-utilization with the caffeine in herbal supplements
(e.g. green tea) for obesity inadvertently produced abnor-
mal cardiovascular, metabolic, and hormonal responses
(CN-00470658). Third, it caused a delay in seeking rele-
vant medical treatments, such as the delay of professional
biomedical treatments for asthma during patients’ self-
care with herbal supplements (PMID 9438488). Children
were significantly less likely to receive vaccinations when
they were seeing a naturopathic physician (PMID
19760163). There were negative associations between
CAM use and Chlamydia screening and between naturop-
athy and mammography among women (PMID 19630554).
There were several specific treatment contexts in
which drug–herb interactions occurred most often. First,
drug–herb interactions occurred in “cross-cultural” or
“multi-cultural” settings in the U.S. Border cities between
the U.S. and Mexico (e.g. El Paso, Texas) were examined
in a number of studies as a difficult social context where
the risk of drug–herb interactions was higher than that
of the general U.S. population (PMID 16396061; PMID
19552494; PMID 18928136). Studies pointed to two con-
tributing factors: 1) higher utilization rates of herbal medi-
cine among residents in border cities and 2) herbal
medicine users’ cross-border healthcare utilization that
made it difficult for healthcare providers on both sides to
trace and coordinate patients’ plural medical behavior.
Another group of reports revealed that adverse drug–
herb interactions were more probable among U.S. immi-
grant minorities, such as Mexican-Americans (PMID
17405676) and Slavic-Americans (PMID 17900071). In
addition, a survey of six university-affiliated outpatient
clinics in California (PMID 17405676) reported that 85
adverse drug–herb interactions were found in 49 pa-
tients (40% of herbal medicine users); 12 potential ad-
verse drug–herb interactions were found in 8 patients
(7% of the users); among these 12 cases, 8 cases were
hypoglycemia among diabetics who took prickly pear
cactus along with biomedical drugs. These 8 cases were
all from first-generation Mexican-Americans who also
tended to use herbal medicine more often than others.
In addition, several categories of users were identified
as most likely to experience adverse treatment interac-
tions. Many cancer patients were using herbal medicine
concurrently with anti-cancer treatments. However, a
significant number of these users did not consult their
doctors (PMID 15856334; PMID 14991387). The same
situation existed among elderly people who were highly
subject to “polypharmacy” (i.e. multiple drugs) and
“polyherbacy” (i.e. multiple herbal remedies) for high
comorbidity (PMID 17785609; PMID 15018694; PMID
15037491). Another category was illicit stimulant users
among whom certain herbal remedies (e.g. yohimbe),
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ical drugs for treating the stimulant users, were wrongfully
promoted as sexual enhancers (PMID 18570167).
Discussion
Japan has integrated acupuncture and herbal medicine
more systemically and formally into the national medical
system than the U.S. In addition, herbal medicine has
been more closely integrated with biomedicine than acu-
puncture in Japan. In the U.S., to the contrary, acupunc-
ture has been incorporated in the system whereas herbal
medicine has not. Although institutionalized more dis-
cursively than systemically, American acupuncture has
been given a similar status in the American medical sys-
tem as Japanese acupuncture has in the Japanese system.
American acupuncture even seems to be positioned bet-
ter. Whereas Japanese acupuncture has been detached
from herbal medicine and the whole system of Japanese
traditional medicine, American acupuncture has not
been explicitly detached from the whole Oriental med-
ical system. Put in an order, Japanese herbal medicine
has been integrated into the national medical system the
most and American herbal medicine the least; American
acupuncture and Japanese acupuncture have fallen in
the middle.
The treatment outcomes of acupuncture and herbal
medicine in Japan and the U.S. correspond with these
differences in institutionalization. First, acupuncture and
herbal medicine that were carefully coordinated with
other treatment options in CENTRAL clinical trials pro-
duced better outcomes, such as more occasions of desir-
able outcomes and biomedicine–CAM synergies with no
reports of adverse treatment effects, compared to MEDLINE
reports that included uncontrolled and uncoordinated real-
world treatment cases. Second, among CENTRAL trials and
among MEDLINE reports, treatment outcomes were the
most favorable for Japanese herbal medicine and the least fa-
vorable for American herbal medicine. The outcomes of
American acupuncture and Japanese acupuncture fell in the
middle. Thus, in Japan, herbal medicine was found to be
more effective than acupuncture; in the U.S., acupuncture
was found more effective than herbal medicine.
This correspondence between the institutionalization
of acupuncture and herbal medicine on one hand and
the CAM treatment outcomes on the other provides
empirical evidence to the notion that the co-utilization
of CAM along with biomedicine involves difficulties for
users and practitioners due to theoretical and political
tensions between the two [16,32,72]. In addition, my
paper further enriches this notion by adding that these
difficulties can be relieved and result in various treat-
ment outcomes of CAM, depending on the extent to
which CAM interventions are coordinated with bio-
medicine. Moreover, through content analysis, my paperprovides an in-depth understanding of social contexts in
which the co-utilization of CAM and biomedicine pro-
duces negative biomedicine–CAM interactions and ad-
verse CAM treatment outcomes. These contexts existed
at several levels, such as regulatory policies, practitioner
expertise, user–provider communication, and users’
cross-cultural health behavior. At the same time, various
types of synergic benefits were evident when CAM and
biomedicine were coordinated in institutional settings.
This paper also supports with ample evidence the
ethnographic insight that institutional settings affect
how unconventional CAM interventions are perceived
and practiced [29]. It further advances this insight by
additionally finding that it is not only the perception
and expectation of medical practices but also their con-
crete treatment outcomes that are affected by institutional
settings. It is possible that effective medical interventions
are more likely to be institutionalized, which is another
empirical question that has yet to be answered. Mean-
while, based on empirical episodes in medical reports, my
current evidence demonstrates that interventions of a
similar nature lead to varying outcomes in different insti-
tutional settings. When the nature (e.g. CAM) is doubted
by dominant theories (e.g. biomedicine) and politics in the
medical field, the sociological perspective that I practiced
in this paper seems to be the one that the sociology of the
effects of medicine and science needs to carry forward.
The literature already evidences that unorthodox and al-
ternative entities are being incorporated into medicine
and science in various manners [73]. It would be even
more fruitful to investigate what effects these different
manners of incorporation produce.
In the sociology of the effects of medicine, broader so-
cial contexts of medical practices have often been held
accountable for the varying treatment outcomes of bio-
medical interventions. This wisdom, however, has not
been seriously applied when considering the varying out-
comes of popular CAM, such as acupuncture and herbal
medicine. The varying outcomes of CAM have instead
been dominantly ascribed to their arguably inferior and
incomplete nature as medical technologies. This asym-
metry is uneasy. When an intervention in biomedicine
does not deliver its expected outcomes, studies have im-
plied that the relationship between medicine and social
contexts should be addressed. In CAM, on the other
hand, the dominant view is that medicine by itself has to
be reengineered, corrected, and improved technologic-
ally. Without addressing this asymmetry, the sociology
of medicine runs the risk of becoming one of the “en-
gines” [74] of “biomedicalization” [75], by inadvertently
stressing social contextual re-organization tuned only to
biomedicine and, simultaneously, the biomedical transform-
ation of CAM. This paper provides a counter-perspective. It
is social contexts as well as medicine by itself that generate
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that social contexts also need to be tuned to CAM in order
to produce better treatment outcomes.
Methodologically, this paper’s content analysis can be
labeled as a sociological meta-analysis, which is in dis-
tinction to meta-analysis in the medical science commu-
nity. Medical meta-analysis aims to produce a model of
the universally consistent effects of medicine by bracket-
ing the contextual differences out of consideration. My
sociological meta-analysis, to the very contrary, purports
to generate a model of the differential effects of medi-
cine by shedding light on the very contextual differences.
There is still room for improvement on this front. My
current meta-analysis is largely a bivariate analysis of the
relationship between treatment outcomes and social
contexts (i.e. the U.S. versus Japan) both quantitatively
and qualitatively. It needs to be expanded into a multi-
variate analysis that can verify the robustness of the find-
ings even in the presence of other covariates. On the
qualitative front, the characteristics of social contexts
can be specified further.Conclusion
Acupuncture and herbal medicine, which have tensions
with the mainstream biomedicine, are institutionalized
differently in Japan and the U.S. Depending on the ex-
tent to which these CAM interventions are coordinated
with biomedicine in the national medical system, they
produce different treatment outcomes. When coordi-
nated with biomedicine, acupuncture and herbal medi-
cine produce more beneficial treatment outcomes.Appendix
One can get the MEDLINE papers that I used for con-
tent analysis, by copying the following search queries
into the search box of PubMed (i.e. the user interface for
the MEDLINE database). There could be minor discrep-
ancies between the materials in this paper (retrieved on
May 9, 2012) and the materials that one gets currently
from the interface. These discrepancies are all additional
materials that are deposited to MEDLINE since I
accessed it.
A. the subset of CAM: cam[sb]
B. acupuncture reports from Japan: japan[MeSH Terms]
AND (acupuncture[MeSH Terms] OR acup* OR acu-
point[MeSH Terms] OR ear acupuncture[MeSH Terms]
OR auricular acupuncture[MeSH Terms] OR analgesia,
acupuncture[MeSH Terms] OR anesthesia, acupuncture
[MeSH Terms])
C. acupuncture reports from the U.S.: united states
[MeSH Terms] AND (acupuncture[MeSH Terms] OR
acup* OR acupoint[MeSH Terms] OR ear acupuncture
[MeSH Terms] OR auricular acupuncture[MeSH Terms]OR analgesia, acupuncture[MeSH Terms] OR anesthesia,
acupuncture[MeSH Terms])
D. herbal medicine reports from Japan: japan[MeSH
Terms] AND (“*herb*” OR “plant extract*” OR “kampo”
OR “kanpo” OR herbal medicine[MeSH Terms] OR
herbal preparation[MeSH Terms] OR herb therapy
[MeSH Terms] OR herbal therapy[MeSH Terms] OR
herb, medicinal[MeSH Terms] OR drug herb interaction
[MeSH Terms] OR herb drug interaction[MeSH Terms]
OR medicinal plant[MeSH Terms] OR medicinal herb
[MeSH Terms] OR phytotherapy[MeSH Terms])
E. herbal medicine reports from the U.S.: united
states [MeSH Terms] AND (“*herb*” OR “plant extract*”
OR “kampo” OR “kanpo” OR herbal medicine[MeSH
Terms] OR herbal preparation[MeSH Terms] OR herb
therapy [MeSH Terms] OR herbal therapy[MeSH Terms]
OR herb, medicinal[MeSH Terms] OR drug herb inter-
action[MeSH Terms] OR herb drug interaction[MeSH
Terms] OR medicinal plant[MeSH Terms] OR medicinal
herb[MeSH Terms] OR phytotherapy[MeSH Terms])
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